CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-18 | Utter Christine Marie SVP, Finance & CAO | Sale | −10,000 | $44.00 | $440K | 26,425 |
| 2022-01-18 | Utter Christine Marie SVP, Finance & CAO | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | $18.01 | $180K | 0 |
| 2022-01-07 | Utter Christine Marie SVP, Finance & CAO | Sale | −747 | $38.53 | $29K | 16,253 |
| 2022-01-07 | Utter Christine Marie SVP, Finance & CAO | Grant or award | +11,600 | 27,853 | ||
| 2022-01-07 | Utter Christine Marie SVP, Finance & CAO | Grant or award · Stock Option (Right to Buy) | +43,500 | 43,500 | ||
| 2022-01-07 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −756 | $38.53 | $29K | 35,058 |
| 2022-01-07 | Almstead Neil Gregory Chief Technical Ops Officer | Grant or award | +14,400 | 49,458 | ||
| 2022-01-07 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −45 | $38.53 | $2K | 1,710 |
| 2022-01-07 | Almstead Neil Gregory Chief Technical Ops Officer | Grant or award | +780 | 2,490 | ||
| 2022-01-07 | Almstead Neil Gregory Chief Technical Ops Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2022-01-07 | Boulding Mark Elliott Exec. VP and CLO | Sale | −885 | $38.53 | $34K | 47,489 |
| 2022-01-07 | Boulding Mark Elliott Exec. VP and CLO | Grant or award | +14,400 | 61,889 | ||
| 2022-01-07 | Boulding Mark Elliott Exec. VP and CLO | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2022-01-07 | Hill Emily Luisa Chief Financial Officer | Sale | −800 | $38.53 | $31K | 22,333 |
| 2022-01-07 | Hill Emily Luisa Chief Financial Officer | Grant or award | +15,600 | 37,933 | ||
| 2022-01-07 | Hill Emily Luisa Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +58,500 | 58,500 | ||
| 2022-01-07 | Klein Matthew B. Chief Operating Officer | Sale | −775 | $38.53 | $30K | 16,461 |
| 2022-01-07 | Klein Matthew B. Chief Operating Officer | Grant or award | +21,000 | 37,461 | ||
| 2022-01-07 | Klein Matthew B. Chief Operating Officer | Grant or award | +20,000 | 57,461 | ||
| 2022-01-07 | Klein Matthew B. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 |
Page 48 of 53 · 1,049 trades